Heterogeneity of the erythrocyte Na-K pump status in human obesity. 1985

R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò

The number of Na-K pump units, the Na-K-ATPase activity, the K transport turnover rate per pump unit and the intracellular Na and K concentrations were measured in the erythrocytes of 56 obese patients and 20 normal subjects. No differences were found between the two groups. In obese patients, we failed to observe any influence of dietary habits, age of onset, or family history of obesity on the Na pump status. On the other hand, we found that the number of pump units was not a close reflection of the membrane cation transport and in some patients with an abnormally high number of pump units, an inappropriately low Na-K-ATPase activity was observed. We also identified two small groups of obese patients with, respectively, abnormally high or low K transport turnover rate per pump unit. Our study seems to support the hypothesis that abnormalities in the erythrocyte Na-K pump system are not usual in the obese population but are probably present only in a limited number of selected patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000254 Sodium-Potassium-Exchanging ATPase An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. ATPase, Sodium, Potassium,Adenosinetriphosphatase, Sodium, Potassium,Na(+)-K(+)-Exchanging ATPase,Na(+)-K(+)-Transporting ATPase,Potassium Pump,Sodium Pump,Sodium, Potassium ATPase,Sodium, Potassium Adenosinetriphosphatase,Sodium-Potassium Pump,Adenosine Triphosphatase, Sodium, Potassium,Na(+) K(+)-Transporting ATPase,Sodium, Potassium Adenosine Triphosphatase,ATPase Sodium, Potassium,ATPase, Sodium-Potassium-Exchanging,Adenosinetriphosphatase Sodium, Potassium,Pump, Potassium,Pump, Sodium,Pump, Sodium-Potassium,Sodium Potassium Exchanging ATPase,Sodium Potassium Pump

Related Publications

R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
November 1982, Metabolism: clinical and experimental,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
April 1983, The Journal of clinical endocrinology and metabolism,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
May 1990, Methods and findings in experimental and clinical pharmacology,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
January 1984, Hypertension (Dallas, Tex. : 1979),
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
January 1982, Biochemical and biophysical research communications,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
March 1986, Pharmacological research communications,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
January 2003, Journal of biomedical science,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
August 1984, Clinica chimica acta; international journal of clinical chemistry,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
January 1988, Methods in enzymology,
R Pasquali, and E Strocchi, and P Malini, and F Casimirri, and N Melchionda, and E Ambrosioni, and G Labò
August 1987, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!